(1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country,

(2005) Anti-tuberculosis drug resistance in Korea,

(1997) Guidelines for the management of drug-resistant tuberculosis, Geneva: World Health Organization

(1997) Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on antituberculosis drug resistance surveillance 1994？1997, Geneva: World Health Organization

(1997) Rapid diagnosis of isoniazid resistance by detection of mutations in katG and inhA of Mycobacterium tuberculosis in Korea,

(1996) The relationship between isoniazid resistance and 463 codon mutation of katG gene in Mycobacterium tuberculosis,

(2002) Worldwide incidence of multidrug-resistant tuberculosis,

(2003) ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates,

(nature1992) The catalase- peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis,

(jbacteriol1993) Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis,

(1996) Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates,

(1997) Lack of clinical significance for the common arginine- to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore,

(science1994) a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis,

(2002) Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis,

(1998) Mechanisms of isoniazid resistance in Mycobacterium tuberculosis enzymatic characterization of enoyl reductase mutants identified in isoniazid resistant clinical isolates,

(1995) Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing,

(1995) New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains,

(2000) Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea,

(1995) Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis,

(1996) Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and isoniazid-susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance,

(1995) Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis,

(1999) Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain,

Honore N, (lancet1994) Implications of multi-drug resistance for the future short-course chemotherapy of tuberculosis,

Rinder H, (1998) Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis,

Silva MS, (2003) Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis,

Lee AS, (1999) Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore,

Lee AS, (2001) Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates,

(1999) Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB),

(1997) Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis,

(1996) katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients,

(jinfectdis1994) Mutations in the catalase- mperoxidase gene from isoniazid resistant Mycobacterium tuberculosis isolates,

(1995) Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance,

(1995) Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis,

(1995) Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis,

(2003) Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania,

(2002) Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain,

(1995) Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare,

(2001) rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism,

(1996) Comparative antimycobacterial activities of rifampin and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations,

(1998) Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis,

(1995) Mutation position and type of substitution in the ？-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis,